Team:Groningen/Template/MODULE/project/MBD/results

From 2014.igem.org

(Difference between revisions)
Line 47: Line 47:
<!-- PARAGRAPH SNIPPET START-->
<!-- PARAGRAPH SNIPPET START-->
<div class="text">
<div class="text">
-
Our results in textformat
+
Final outcome of the modeling is that design 1 is the best, with all the cells evenly distributed throughout the hydrogel.
</div>
</div>
<div class="hspacer">&nbsp;</div>
<div class="hspacer">&nbsp;</div>
Line 55: Line 55:
<!-- FIGURE SNIPPET START -->
<!-- FIGURE SNIPPET START -->
-
</html>{{:Team:Groningen/Template/MODULE/newfigure|Figure 1|....|
+
</html>{{:Team:Groningen/Template/MODULE/newfigure|Figure 1|6/6d/Model1lactoaid.png|
-
Proin finibus nisi ut enim fermentum finibus ut egestas dolor. Vestibulum cursus eu dolor vehicula faucibus. Sed sed pharetra arcu. Pellentesque venenatis viverra justo a aliquet. Pellentesque venenatis viverra justo a aliquet. Praesent sit amet metus in ligula porttitor maximus. Pellentesque varius ligula lacus.
+
The best design for our purposes.
}}<html>
}}<html>
<!-- FIGURE SNIPPET END-->
<!-- FIGURE SNIPPET END-->

Revision as of 23:30, 17 October 2014

Conclusion
 
DesignTnisinTAiiATDspBRating
13 hsomethingsomethingsomething
2?After being applied to the wound. Amount of time for reaching the inhibitory concentrations of nisin, DspB and AiiA to pass the bottom membrane and into the wound.
3 tbdIn what quantity does S. aureus need to be detected?
4tbdIn what quantity does P. aeruginosa need to be detected?
52-16 ng/µLThis concentration can be used for both MRSA and VRE. Source: Nisin, alone and combined with peptidoglycan-modulating antibiotics: activity ……. Brumfitt, Salton, Hamilton-Miller.
6tbdHow much is needed to inhibit growth of PA/SA?
Final outcome of the modeling is that design 1 is the best, with all the cells evenly distributed throughout the hydrogel.
 
Figure 1
 
Figure 1: The best design for our purposes.